Not logged in Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases―the PURPLE trial Kasper, S.; Elez, E.; Neumann, U.; Lang, S.; Trampe, A. -K.; Salva, F.; Dopazo, C.; Virchow, I.; Hartmann, S.; Herrmann, K.; Tabernero, J.; Westendorf, A.; Schuler, M.; Schramm, A. Share Save
Second interim analysis of INFINITY: A registry on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice Martens, U. M.; Schroeder, J.; Sellmann, L.; Reiser, M.; Frank-Gleich, S.; Decker, T.; Schneeweiss, A.; Schuler, M.; Grebhardt, S.; Woerner, S.; Zacharias, S.; Marschner, N. W.; Kasenda, B.; Vannier, C. Share Save
Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET plus MTC) Keam, B.; Hu, M. I.; Subbiah, V.; Wirth, L.; Schuler, M.; Mansfield, A. S.; Brose, M. S.; Curigliano, G.; Leboulleux, S.; Zhu, V. W.; Matos, I.; Adkins, D.; Baik, C. S.; Lopes, G.; Godbert, Y.; Sarker, D.; Zhang, H.; Turner, C. D.; Taylor, M. H.; Lin, C-C. Share Save
Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET plus MTC) Hu, M.; Subbiah, V.; Wirth, L. J.; Schuler, M.; Mansfield, A. S.; Brose, M. S.; Curigliano, G.; Leboulleux, S.; Zhu, V. W.; Keam, B.; Matos, I.; Lin, C-C.; Adkins, D.; Baik, C. S.; Lopes, G.; Godbert, Y.; Sarker, D.; Zhang, H.; Turner, C.; Taylor, M. Share Save
Phase I study of the pan-fibroblast growth factor receptor (FGFR) inhibitor BAY 1163877 with expansion cohorts for subjects based on tumor FGFR mRNA expression levels Joerger, M.; Soo, R.; Cho, B. C.; Navarro Mendivil, A.; Sayehli, C.; Richly, H.; Tai, D.; Kim, D. -W.; Wolf, J.; Cassier, P.; Ellinghaus, P.; Hildebrandt, S.; Behre, S.; Helmbrecht, C.; Kerpen, S.; Zielinski, D.; Ince, S.; Rajagopalan, P.; Ocker, M.; Schuler, M. Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}